Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-11T08:34:53.416Z Has data issue: false hasContentIssue false
  • English
  • Français

A Protected Class, An Unprotected Condition, and A Biomarker – A Method/Formula for Increased Diversity in Clinical Trials for the African American Subject with Benign Ethnic Neutropenia (BEN) – CORRIGENDUM

Published online by Cambridge University Press:  19 July 2023

Regina Ponder
Regina Ponder*
Affiliation:
National Coalition of 100 Black Women, Inc., Phoenix Metropolitan Chapter, Phoenix, AZ, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Corrigendum
Information
American Journal of Law & Medicine , Volume 49 , Issue 4 , December 2023 , pp. 525
Copyright
© 2023 The Author(s)

In the initial publication of Ponder (Reference Ponder2023), the author’s email address was printed incorrectly. The correct email address is reproduced below:

The original publication has been updated to reflect this change.

References

Ponder, R. (2023), “A Protected Class, An Unprotected Condition, and A Biomarker – A Method/Formula for Increased Diversity in Clinical Trials for the African American Subject with Benign Ethnic Neutropenia (BEN),” American Journal of Law & Medicine, 49(1), pp. 41–58.10.1017/amj.2023.15CrossRefGoogle Scholar